NetworkNewsBreaks – Isracann Biosciences Inc. (CSE: IPOT) Announces CSE Listing and Investor Relations Agreements
Isracann Biosciences (CSE: IPOT), formerly Atlas Blockchain Group Inc. (XFRA: A49) (OTC: ATLEF), today announced fulfillment of all conditions of its reverse takeover transaction and that it has met all conditions to list on the Canadian Securities Exchange. According to the update, the company commenced trading at market open on October 17, 2019. In addition, Isracann announced its entry into contractual agreements with multiple service providers, including CFN Media, Stonebridge Partners, Investing News Network, Business Television (“BTV”), Equity Guru, BlackX Management, Mountain Capital, and Invictus IR, for marketing, communication, shareholder engagement and social media communications. The marketing and communication program…







